Clinical evaluation of co-trimoxazole and furazolidone in treatment of shigellosis in children.
作者信息
Lexomboon U, Mansuwan P, Duangmani C, Benjadol P, M'cMinn M T
出版信息
Br Med J. 1972 Jul 1;3(5817):23-6. doi: 10.1136/bmj.3.5817.23.
Abstract
Co-trimoxazole (trimethoprim-sulphamethoxazole) was compared with furazolidone in the treatment of shigellosis in two groups of 33 and 30 patients respectively. Those treated with co-trimoxazole recovered more quickly; none had shigellae in the faeces four days after the start of treatment, whereas in the group given furazolidone eight still had positive stool cultures seven days after treatment.The susceptibility of 104 shigella strains to seven antimicrobial agents was studied by plate dilution technique. All agents but tetracycline and chloramphenicol were found highly effective against most of the strains tested. All shigella isolates were resistant to sulphamethoxazole, and 63% were sensitive to trimethoprim. Potentiation of trimethoprim by sulphamethoxazole was shown in that all strains tested became sensitive to the combination of trimethoprim and sulphamethoxazole in a ratio of 1:20.
摘要
相似文献
1
Clinical evaluation of co-trimoxazole and furazolidone in treatment of shigellosis in children.
Br Med J. 1972 Jul 1;3(5817):23-6. doi: 10.1136/bmj.3.5817.23.
2
Clinical trial of ampicillin v. trimethoprim-sulphamethoxazole in the treatment of Shigella dysentery.
J Trop Med Hyg. 1982 Oct;85(5):195-9.
3
A controlled clinical trial of trimethoprim-sulphamethoxazole in shigella dysentery.
J Trop Med Hyg. 1974 Mar;77(3):50-4.
4
[Experience with the combination sulfamethoxazole and trimethoprim in the treatment of Shigella-Flexner infections].
Arzneimittelforschung. 1971 May;21(5):599-600.
5
Shigella species from Addis Ababa: frequency of isolation and in vitro drug sensitivity.
J Hyg (Lond). 1982 Feb;88(1):47-55. doi: 10.1017/s0022172400069886.
6
Trimethoprim-sulfamethoxazole therapy for shigellosis.
JAMA. 1976 Mar 22;235(12):1239-43.
7
Trimethoprim-sulphamethoxazole in enteric infections.
Scand J Infect Dis. 1972;4(3):231-40. doi: 10.3109/inf.1972.4.issue-3.10.
8
Antimicrobial resistance of Shigellae isolated in Michigan.
JAMA. 1975 Mar 17;231(11):1159-61.
9
Combination of trimethoprim and sulphamethoxazole in typhoid fever.
S Afr Med J. 1972 Mar 11;46(11):281-4.
10
Bacteriological evaluation of the course of urinary tract infections treated with trimethoprim and-or sulphamethoxazole.
Acta Chir Scand Suppl. 1973;433:102-9.
引用本文的文献
1
Efficacy and potential of phage therapy against multidrug resistant spp.
PeerJ. 2019 Apr 5;7:e6225. doi: 10.7717/peerj.6225. eCollection 2019.
2
Antibiotic therapy for Shigella dysentery.
Cochrane Database Syst Rev. 2010 Aug 4;2010(8):CD006784. doi: 10.1002/14651858.CD006784.pub4.
3
Pharmacoeconomics of the therapy of diarrhoeal disease.
Pharmacoeconomics. 1992 Oct;2(4):305-23. doi: 10.2165/00019053-199202040-00006.
4
Shigella species from Addis Ababa: frequency of isolation and in vitro drug sensitivity.
J Hyg (Lond). 1982 Feb;88(1):47-55. doi: 10.1017/s0022172400069886.
5
Furazolidone versus ampicillin in the treatment of traveler's diarrhea.
Antimicrob Agents Chemother. 1984 Aug;26(2):160-3. doi: 10.1128/AAC.26.2.160.
6
In vitro susceptibility of Shigella strains to trimethoprim and sulfamethoxazole.
Antimicrob Agents Chemother. 1974 May;5(5):439-43. doi: 10.1128/AAC.5.5.439.
7
Antimicrobial susceptibilities of shigellae isolated in Houston, Texas, in 1974.
Antimicrob Agents Chemother. 1976 Feb;9(2):288-91. doi: 10.1128/AAC.9.2.288.
8
Rifampicin therapy in shigellosis in infancy.
Arch Dis Child. 1977 Dec;52(12):960-1. doi: 10.1136/adc.52.12.960.
本文引用的文献
1
EPITHELIAL CELL PENETRATION AS AN ESSENTIAL STEP IN THE PATHOGENESIS OF BACILLARY DYSENTERY.
J Bacteriol. 1964 Nov;88(5):1503-18. doi: 10.1128/jb.88.5.1503-1518.1964.
2
DIARRHEAL DISEASES OF CHILDREN. THE OCCURRENCE OF ENTEROPATHOGENIC VIRUSES AND BACTERIA.
Am J Dis Child. 1964 Mar;107:218-31. doi: 10.1001/archpedi.1964.02080060220002.
3
Shigellosis and sulphonamides.
Lancet. 1960 Aug 27;2(7148):460-1. doi: 10.1016/s0140-6736(60)91593-2.
4
Observations on resistance to sulfadiazine and antibiotics in shigellosis.
Am J Trop Med Hyg. 1958 Jan;7(1):51-7. doi: 10.4269/ajtmh.1958.7.51.
5
Double-blind treatment study of shigellosis comparing ampicillin, sulfadiazine, and placebo.
J Pediatr. 1967 Jun;70(6):970-81. doi: 10.1016/s0022-3476(67)80275-0.
6
[Resistance determinations in microorganisms causing dysenteria with regard to sulfamethoxazol-trimethoprim].
Arzneimittelforschung. 1971 May;21(5):597-8.
7
[Experience with the combination sulfamethoxazole and trimethoprim in the treatment of Shigella-Flexner infections].
Arzneimittelforschung. 1971 May;21(5):599-600.
8
Colicin typing as an epidemiological tool in the investigation of outbreaks of Shigella sonnei.
Appl Microbiol. 1971 Jan;21(1):21-6. doi: 10.1128/am.21.1.21-26.1971.
9
Determination of biotype, phage type and colicinogenic character of Shigella sonnei, and its epidemiologic importance.
Arch Immunol Ther Exp (Warsz). 1968;16(3):421-8.
10
Observations on the association of enteric viruses and bacteria with diarrhea.
Am J Trop Med Hyg. 1967 Mar;16(2):178-85. doi: 10.4269/ajtmh.1967.16.178.
Zotero 插件